Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease

被引:158
作者
Sid, Brice [1 ]
Verrax, Julien [1 ]
Calderon, Pedro Buc [1 ,2 ]
机构
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Toxicol & Canc Biol Res Grp GTOX, B-1200 Brussels, Belgium
[2] Univ Arturo Prat, Fac Ciencias Salud, Iquique, Chile
关键词
AMPK; Oxidative stress; Cell survival; Autophagy; Alcohol-liver disease; KINASE-C-ZETA; PROTEIN-KINASE; FATTY LIVER; MITOCHONDRIAL DYSFUNCTION; GLUCOSE DEPRIVATION; PROTECTIVE ACTION; IN-VIVO; AUTOPHAGY; ETHANOL; APOPTOSIS;
D O I
10.1016/j.bcp.2013.05.007
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Chronic alcohol consumption is a well-known risk factor for liver disease. Progression of alcohol-induced liver disease (ALD) is a multifactorial process that involves a number of genetic, nutritional and environmental factors. Experimental and clinical studies increasingly show that oxidative damage induced by ethanol contributes in many ways to the pathogenesis of alcohol hepatoxicity. Oxidative stress appears to activate AMP-activated protein kinase (AMPK) signaling system, which has emerged in recent years as a kinase that controls the redox-state and mitochondrial function. This review focuses on the most recent insights concerning the activation of AMPK by reactive oxygen species (ROS), and describes recent evidences supporting the hypothesis that AMPK signaling pathways play an important role in promoting cell viability under conditions of oxidative stress, such as during alcohol exposure. We suggest that AMPK activation by ROS can promote cell survival by inducing autophagy, mitochondrial biogenesis and expression of genes involved in antioxidant defense. Hence, increased intracellular concentrations of ROS may represent a general mechanism for enhancement of AMPK-mediated cellular adaptation, including maintenance of redox homeostasis. On the other hand, AMPK inhibition in the liver by ethanol appears to play a key role in the development of steatosis induced by chronic alcohol consumption. Although more studies are needed to assess the functions of AMPK during oxidative stress, AMPK may be a possible therapeutic target in the particular case of alcohol-induced liver disease. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:200 / 209
页数:10
相关论文
共 112 条
[1]
ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS [J].
Alexander, Angela ;
Cai, Sheng-Li ;
Kim, Jinhee ;
Nanez, Adrian ;
Sahin, Mustafa ;
MacLean, Kirsteen H. ;
Inoki, Ken ;
Guan, Kun-Liang ;
Shen, Jianjun ;
Person, Maria D. ;
Kusewitt, Donna ;
Mills, Gordon B. ;
Kastan, Michael B. ;
Walker, Cheryl Lyn .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (09) :4153-4158
[2]
Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway [J].
Almeida, A ;
Moncada, S ;
Bolaños, JP .
NATURE CELL BIOLOGY, 2004, 6 (01) :45-U9
[3]
The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells [J].
Alves, Nuno L. ;
Derks, Ingrid A. M. ;
Berk, Erik ;
Spijker, Rene ;
van Lier, Rene A. W. ;
Eldering, Eric .
IMMUNITY, 2006, 24 (06) :703-716
[4]
[Anonymous], 2011, PLOS ONE
[5]
[Anonymous], 2001, MOL CELL BIOL, V21, P5742
[6]
Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt [J].
Asnaghi, L ;
Calastretti, A ;
Bevilacqua, A ;
D'Agnano, I ;
Gatti, G ;
Canti, G ;
Delia, D ;
Capaccioli, S ;
Nicolin, A .
ONCOGENE, 2004, 23 (34) :5781-5791
[7]
Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI 10.1089/ARS.2008.2270
[8]
ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage [J].
Barzilai, A ;
Rotman, G ;
Shiloh, Y .
DNA REPAIR, 2002, 1 (01) :3-25
[9]
Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis [J].
Bergeron, R ;
Ren, JM ;
Cadman, KS ;
Moore, IK ;
Perret, P ;
Pypaert, M ;
Young, LH ;
Semenkovich, CF ;
Shulman, GI .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 281 (06) :E1340-E1346
[10]
Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients [J].
Boon, H. ;
Bosselaar, M. ;
Praet, S. F. E. ;
Blaak, E. E. ;
Saris, W. H. M. ;
Wagenmakers, A. J. M. ;
Mcgee, S. L. ;
Tack, C. J. ;
Smits, P. ;
Hargreaves, M. ;
van Loon, L. J. C. .
DIABETOLOGIA, 2008, 51 (10) :1893-1900